Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis
Authors
Cheok, K. P. L.Kirkwood, A. A.
Menne, T.
Tholouli, E.
Chaganti, S.
Mathew, A.
Uttenthal, B.
Russell, J.
Irvine, D.
Johnson, R.
Nicholson, E.
Bazin, J.
Townsend, W.
Kuhnl, A.
O'Reilly, M.
Sanderson, R.
Patel, Amit
Roddie, C.
Affiliation
Department of Hematology, University College London, London, UK.Issue Date
2022
Metadata
Show full item recordCitation
Cheok KPL, Kirkwood AA, Menne T, Tholouli E, Chaganti S, Mathew A, et al. Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis. Leukemia & Lymphoma. Informa UK Limited; 2022. p. 1–5.Journal
Leukemia and LymphomaDOI
10.1080/10428194.2022.2057487PubMed ID
35481791Additional Links
https://dx.doi.org/10.1080/10428194.2022.2057487Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1080/10428194.2022.2057487
Scopus Count
Collections
Related articles
- Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
- Authors: Madduri D, Parekh S, Campbell TB, Neumann F, Petrocca F, Jagannath S
- Issue date: 2021 Feb 19
- Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients.
- Authors: Wu X, Wang L, Shen L, He L, Tang K
- Issue date: 2022 Jun 16
- Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
- Authors: Hong R, Zhao H, Wang Y, Chen Y, Cai H, Hu Y, Wei G, Huang H
- Issue date: 2021 Mar
- Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient.
- Authors: Abbasi J
- Issue date: 2021 Mar 9
- An update on ICU outcomes in patients after CAR T therapy: A four-year tertiary UK centre experience.
- Authors: Scourfield L, Pirani T, Singh N, Saha R, Kuhnl A, Sanderson R, Metaxa V
- Issue date: 2024 Apr